Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May 16;23(5):933-40.
doi: 10.1021/bc2005158. Epub 2012 May 2.

Development of a low toxicity, effective pDNA vector based on noncovalent assembly of bioresponsive amino-β-cyclodextrin:adamantane-poly(vinyl alcohol)-poly(ethylene glycol) transfection complexes

Affiliations

Development of a low toxicity, effective pDNA vector based on noncovalent assembly of bioresponsive amino-β-cyclodextrin:adamantane-poly(vinyl alcohol)-poly(ethylene glycol) transfection complexes

Aditya Kulkarni et al. Bioconjug Chem. .

Abstract

A host:guest-derived gene delivery vector has been developed, based on the self-assembly of cationic β-CD derivatives with a poly(vinyl alcohol) (MW 27 kDa) (PVA) main chain polymer bearing poly(ethylene glycol) (MW 750) (PEG) or MW 2000 PEG and acid-labile adamantane-modified (Ad) grafts through an acid-sensitive benzylidene acetal linkage. These components were investigated for their ability to promote supramolecular complex formation with pDNA using two different assembly schemes, involving either precomplexation of the pendent Ad-PVA-PEG polymer with the cationic β-CD derivatives before pDNA condensation (method A) or pDNA condensation with the cationic β-CD derivatives prior to addition of Ad-PVA-PEG to engage host:guest complexation (method B). The pendent polymers were observed to degrade under acidic conditions while remaining intact for more than 5 days at pH 7. HeLa cell culture data show that these materials have 10(3)-fold lower cytotoxicities than 25 kDa bPEI while maintaining transfection efficiencies that are superior to those observed for this benchmark cationic polymer transfection reagent when the method A assembly scheme is employed. These findings suggest that degradable cationic polymer constructs employing multivalent host:guest interactions may be an effective and low-toxicity vehicle for delivering nucleic acid cargo to target cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structures of amino-β-CDs, Ad-PVA-PEG750 and Ad-PVA-PEG2000.
Figure 2
Figure 2
400 MHz 1H NMR spectra of Ad-PVA-PEG in the absence (A), in the presence (B) of β-CD; Ad-PVA in the absence (C), and presence (D) of β-CD in D2O at 20 °C, and Ad-PVA with β-CD at pH = 7 (E) and pH = 4 (F) in D2O at 20 °C.
Figure 3
Figure 3
(A) Zeta potential measurements of pDNA:amino-β-CD complexes and pDNA:bPEI complexes. DLS Measurements of (B) pDNA:1:Ad-PVA-PEG750 and pDNA:3:Ad-PVA-PEG750 complexes formulated by Method A and (C) pDNA:3 and pDNA:3:Ad-PVA-PEG750 complexes formulated by Method B.
Figure 4
Figure 4
AFM images of (A) Ad-PVA-PEG750 and (B) 1:1 β-CD:Ad-PVA-PEG750. Images of pDNA:3:Ad-PVA-PEG750 prepared by Method B at (C) N:P = 2 and (D) N:P = 6. The insets illustrate the possible structures in these images. The samples were prepared by adding a drop of solution to the mica surface and then slowly evaporating the sample at 25 °C overnight.
Figure 5
Figure 5
Cytotoxicities of 1, 2, 3, Ad-PVA-PEG750 and 1:Ad-PVA-PEG750 host:guest complexes in HeLa cells using 25kD bPEI as a control. The cells were treated with increasing concentrations of amino-β-CDs, 1:Ad-PVA-PEG750 complexes, and bPEI for 24 h in serum-free media before analysis by MTT assay.
Figure 6
Figure 6
In vitro transfection efficiencies of amino-β-CD host:guest complexes with (A) Ad-PVA-PEG750 and mhGFP pDNA (B) Ad-PVA-PEG2000 and mhGFP pDNA in HeLa cells; with 25kD bPEI (control) considered as 100% transfection efficiency. Fluorescence microscope images of transfected HeLa cells (C) bPEI 25k, (D) 3:Ad-PVA-PEG750 using Method A at N:P = 20 in serum-free media using GFP gene as a reporter gene; scale bar: 100μm.

Similar articles

Cited by

References

    1. Mancuso K, Hauswirth WW, Li Q, Connor TB, Kuchenbecker JA, Mauck MC, Neitz J, Neitz M. Gene therapy for red–green colour blindness in adult primates. Nature. 2009;461:784–8. - PMC - PubMed
    1. Waehler R, Russell SJ, Curiel DT. Engineering targeted viral vectors for gene therapy. Nature Rev Genet. 2007;8:573–587. - PMC - PubMed
    1. Semple SC, Akinc A, Chen J, Sandhu AP, Mui BL, Cho CK, Sah DWY, Stebbing D, Crosley EJ, Yaworski E, Hafez IM, Dorkin JR, Qin J, Lam K, Rajeev KG, Wong KF, Jeffs LB, Nechev L, Eisenhardt ML, Jayaraman M, Kazem M, Maier MA, Srinivasulu M, Weinstein MJ, Chen Q, Alvarez R, Barros SA, De S, Klimuk SK, Borland T, Kosovrasti V, Cantley WL, Tam YK, Manoharan M, Ciufolini MA, Tracy MA, de Fougerolles A, MacLachlan I, Cullis PR, Madden TD, Hope MJ. Rational design of cationic lipids for siRNA delivery. Nature Biotech. 2010;20:172–6. - PubMed
    1. Davis ME, Zuckerman JE, Choi CHJ, Seligson D, Tolcher A, Alabi CA, Yen Y, Heidel JD, Ribas A. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature. 2010;464:1067–70. - PMC - PubMed
    1. Nayak S, Herzog RW. Progress and Prospects: Immune Responses to Viral Vectors. Gene Ther. 2010;17:295–304. - PMC - PubMed

Publication types